AR041557A1 - Suspension de composicion de antigeno con elevada adsorcion del antigeno de superficie de la hepatitis b y estabilidad global - Google Patents

Suspension de composicion de antigeno con elevada adsorcion del antigeno de superficie de la hepatitis b y estabilidad global

Info

Publication number
AR041557A1
AR041557A1 ARP030103666A ARP030103666A AR041557A1 AR 041557 A1 AR041557 A1 AR 041557A1 AR P030103666 A ARP030103666 A AR P030103666A AR P030103666 A ARP030103666 A AR P030103666A AR 041557 A1 AR041557 A1 AR 041557A1
Authority
AR
Argentina
Prior art keywords
antigen
hepatitis
suspension
composition
adsortion
Prior art date
Application number
ARP030103666A
Other languages
English (en)
Spanish (es)
Original Assignee
Evans Vaccines
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evans Vaccines filed Critical Evans Vaccines
Publication of AR041557A1 publication Critical patent/AR041557A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ARP030103666A 2002-10-08 2003-10-08 Suspension de composicion de antigeno con elevada adsorcion del antigeno de superficie de la hepatitis b y estabilidad global AR041557A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0223355.9A GB0223355D0 (en) 2002-10-08 2002-10-08 Vaccine

Publications (1)

Publication Number Publication Date
AR041557A1 true AR041557A1 (es) 2005-05-18

Family

ID=9945519

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030103666A AR041557A1 (es) 2002-10-08 2003-10-08 Suspension de composicion de antigeno con elevada adsorcion del antigeno de superficie de la hepatitis b y estabilidad global

Country Status (5)

Country Link
KR (1) KR20030083665A (zh)
CN (2) CN102716477B (zh)
AR (1) AR041557A1 (zh)
GB (1) GB0223355D0 (zh)
MY (1) MY151414A (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20100365A1 (es) 2008-10-24 2010-05-21 Panacea Biotec Ltd Novedosas vacunas de combinacion con tos ferina de celulas enteras y metodo para su elaboracion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2118963T3 (es) * 1992-05-23 1998-10-01 Smithkline Beecham Biolog Vacunas combinadas, que contienen antigeno de superficie de la hepatitis b y otros antigenos.
GB9806456D0 (en) * 1998-03-25 1998-05-27 Smithkline Beecham Biolog Vaccine composition

Also Published As

Publication number Publication date
KR20030083665A (ko) 2003-10-30
CN102716477B (zh) 2015-07-29
CN1550236B (zh) 2012-06-20
GB0223355D0 (en) 2002-11-13
CN1550236A (zh) 2004-12-01
CN102716477A (zh) 2012-10-10
MY151414A (en) 2014-05-30

Similar Documents

Publication Publication Date Title
AR051735A1 (es) Inhibidores pirrolicos de la proteina quinasa erk, sintesis e intermediarios de los mismos.
BRPI0215331B8 (pt) composições aquosas contendo metronidazol
IS3686A7 (is) Stöðugar (óhvarfgjarnar) lausnir með örsmáum bólum sem hægt er að dæla í lífverur
AR035933A1 (es) Un compuesto derivado de fosfonato nucleosido aciclico, uso del mismo, un proceso para su preparacion y un compuesto de fosfonato.
AR045595A1 (es) Composiciones utiles como inhibidores de proteinas quinasas
HRP20100056T1 (hr) Endoparaziticidna sredstva za lokalnu primjenu
BR0211390A (pt) Tratamento de infecções da unha com no
NZ586439A (en) Method for peforming an immunodiffusion assay (SRID) for influenza hemagglutinin antigen based on desorbing the antigen from the aluminium adjuvant salt
AR014762A1 (es) PROCEDIMIENTO PARA REDUCIR LA INTERFERENCIA DE COMPONENTES POLISACARIDOS CAPSULARES, DE VACUNAS CONJUGADAS DE HAEMOPHILUS INFLUENZAE B (Hib) EN VACUNASDE COMBINACION, VACUNAS DE COMBINACION OBTENIDAS CON DICHO PROCEDIMIENTO DE VACUNACION CONTRA LA DIFTERIA, TETANO, PERTUSSIS Y HAEMOPHILUS INFLUENZAE
BR112017015958A2 (pt) material de base transdermicamente absorvível contendo composto lípido-péptido
UY28897A1 (es) Ácido 2-((2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil)amino)-3-(fenilpiridin-2-ilamino)propiónico sustancialmente puro como inhibidor de la cinasa ikb
CO6220960A2 (es) Compuesto de piperazina novedoso y uso del mismo como inhibidor de polimerasa del virus de la hepatitis c
AR074627A1 (es) Resinas de melamina urea formaldehido estables durante el almacenamiento y aplicaciones de las mismas
MXPA05014232A (es) Composiciones farmaceuticas estables de 5,10-metilentetrahidrofolato.
AR041557A1 (es) Suspension de composicion de antigeno con elevada adsorcion del antigeno de superficie de la hepatitis b y estabilidad global
KR870006901A (ko) 인터로이킨-2 조성물의 제조방법
BR0108075A (pt) Composição amaciante de tecido,e,uso de um ácido c18-c24-graxo insaturado
ATE6520T1 (de) Dimethylaminoderivate enthaltende haertbare gemische.
EA200501046A1 (ru) Эсциталопрамгидробромид и способ его получения
AR036601A1 (es) Envase hidrosoluble con colorante fluorescente en la pelicula
AR045668A1 (es) Mezcla de agentes tensioactivos y solventes
CU22871A1 (es) Formulaciones conteniendo partículas semejantes a virus como inmunopotenciadores por vía mucosal
AR023136A1 (es) Composiciones acuosas mejoradas
DE60120120D1 (de) Beutelformzusammensetzungen
EA200500369A1 (ru) Материал покрытия, способ его приготовления и нанесения на деревянную подложку

Legal Events

Date Code Title Description
FC Refusal